Paxos has integrated XRP into its regulated Crypto Brokerage platform, enabling businesses using its infrastructure to offer XRP for buying, selling, holding, deposits, and withdrawals. This update expands Paxos' asset roster to 29 and supports over 8.1 million XRP wallets with a market cap near $95 billion. While this does not guarantee XRP availability on platforms like PayPal or Venmo, it enhances Paxos' crypto services under its national-trust-bank framework approved by U.S. regulators. This move could facilitate broader adoption of XRP through financial companies leveraging Paxos' custody and liquidity services.
The news about Paxos adding XRP support provides context for readers interested in crypto infrastructure. For readers following the broader crypto market, here is Pluang's market snapshot as of Oct 08, 2026 10:32 WIB: out of 50 major cryptocurrencies, 18 rose and 31 fell. Notable movers include ONE at Rp39 with a -4.38% change, VET at Rp142 with a -4.04% change, and UNI at Rp140.861 with a -3.88% change.
The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
